🇺🇸 FDA
Patent

US 10450285

2-benzoylaminobenzamide derivatives as Bcl-3 inhibitors

granted A61KA61K31/167A61K31/40

Quick answer

US patent 10450285 (2-benzoylaminobenzamide derivatives as Bcl-3 inhibitors) held by University College Cardiff Consultants Limited expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
University College Cardiff Consultants Limited
Grant date
Tue Oct 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K31/167, A61K31/40, A61K31/4402, A61K31/4453